AAAAAA
Results:
1-7
|
Results: 7
Authors:
Busse, D
Yakes, FM
Lenferink, AEG
Arteaga, CL
Citation: D. Busse et al., Tyrosine kinase inhibitors: Rationale, mechanisms of action, and implications for drug resistance, SEMIN ONCOL, 28(5), 2001, pp. 47-55
Authors:
Busse, D
Fromm, MF
Morike, K
Drescher, S
Kuhlkamp, V
Eichelbaum, M
Citation: D. Busse et al., Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: An investigation comparing single and multiple dosing, CLIN PHARM, 69(5), 2001, pp. 324-332
Authors:
Lenferink, AEG
Busse, D
Flanagan, WM
Yakes, FM
Arteaga, CL
Citation: Aeg. Lenferink et al., ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways, CANCER RES, 61(17), 2001, pp. 6583-6591
Authors:
Busse, D
Doughty, RS
Arteaga, CL
Citation: D. Busse et al., HER-2/neu (erbB-2) and the cell cycle, SEMIN ONCOL, 27(6), 2000, pp. 3-8
Authors:
Busse, D
Citation: D. Busse, The Encyclopedia of Paper, Z BIBL BIBL, 47(3), 2000, pp. 280-282
Authors:
Busse, D
Doughty, RS
Ramsey, TT
Russell, WE
Price, JO
Flanagan, WM
Shawver, LK
Arteaga, CL
Citation: D. Busse et al., Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity, J BIOL CHEM, 275(10), 2000, pp. 6987-6995
Authors:
Busse, D
Busch, FW
Schweizer, E
Bohnenstengel, F
Eichelbaum, M
Fischer, P
Schumacher, K
Aulitzky, WE
Kroemer, HK
Citation: D. Busse et al., Fractionated administration of high-dose cyclophosphamide: influence on dose-dependent changes in pharmacokinetics and metabolism, CANC CHEMOT, 43(3), 1998, pp. 263-268
Risultati:
1-7
|